Landscapes / Targets
CXCR4
3 drugs act on CXCR4, in 4 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Mavorixafornot checked |
CXC chemokine receptor 4 antagonist |
Approved | Sep 2027Phase 3 trial completes | ||
| Next date | Sep 2027 · Phase 3 trial completes | ||||
| Also tested for | Neutropenia, Acquired Primary Autoimmune and Idiopathic Chronic Neutropenia Disorders and 3 more | ||||
| Open drug page | |||||
— |
Approved | — | |||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Approved | — | |||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 3 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026